Publications

5674 Results

A phase II study of menogaril (NSC-269148) in colorectal carcinoma. A Southwest Oncology Group study.

Authors
RP Whitehead;RH Earhart;T Fleming;P Goodman;JS Macdonald;T Pollock;JS Ungerleider
Journal / Conference
IND 8:295-297
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8565

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors
CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;PJ Goodman;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard
Journal / Conference
NEJM 322:352-358
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

Authors
KE Noonan;C Beck;TA Holzmayer;JE Chin;JS Wunder;IL Andulis;AF Gazdar;CL Willman;BB Griffith;DD Von Hoff;IB Roninson
Journal / Conference
Proceedings National Academy of Science USA 87:7160-7164
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

N-ras mutations in adult de novo acute myelogenous leukemia: Prevalence and clinical significance.

Authors
JP Radich;KJ Kopecky;CL Willman;J Weick;D Head;F Appelbaum;SJ Collins
Journal / Conference
Blood 75(4):801-807
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

Cloning and characterization of the (15;17) translocation break point region in acute promyelocytic leukemia.

Authors
RS Lemons;D Eilender;R Waldmann;M Rebentisch;A Frej;D Ledbetter;C Willman;T McConnell;P O'Connell
Journal / Conference
Genes Chromosomes and Cancer 2:79-87
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

A phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma: A Southwest Oncology Group study.

Authors
MB Edelstein;JJ Crowley;FA Valeriote;JD Bonnet;JO Carden;RC Khanna;SE Salmon;JS Ungerleider
Journal / Conference
IND 8:S83-S86
Year
1990
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8604

Treatment of small cell lung cancer with an alternating chemotherapy regimen given at weekly intervals. A Southwest Oncology Group study.

Authors
CW Taylor;J Crowley;SK Williamson;TP Miller;SA Taylor;PG Giri;RL Stephens;RB Livingston
Journal / Conference
JCO 8(11):1811-1817
Year
1990
Research Committee(s)
Lung
Study Number(s)
SWOG-8606

Phase II trial of high dose intermittent interleukin-2 in metastatic renal cell carcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;P Goodman;ED Crawford;JS Sergi;BG Redman;RP Whitehead
Journal / Conference
JNCI 82(3):143-146
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8617

Phase II evaluation of recombinant gamma interferon (r-GIFN) in patients with advanced pancreatic carcinoma: A Southwest Oncology Group study.

Authors
DD Von Hoff;T Fleming;JS Macdonald;PJ Goodman;J Van Damme;TD Brown;T O'Rourke;LG Feun;MD Keppen
Journal / Conference
JBRM 9:584-587
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8626

Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma: A Southwest Oncology Group study.

Authors
JP Kuebler;PJ Goodman;TD Brown;ED Crawford;CL Reitz;WA Knight III;JA Kish
Journal / Conference
IND 8:307-309
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8707